AbbVie Inc. (NYSE:ABBV) ranks among the top picks for a retirement portfolio. The FDA received a New Drug Application from ...

For more than a decade, Carnegie Mellon neuroscientist Aryn Gittis has been unraveling the mystery of how the brain controls movement — research now pointing toward new treatments for Parkinson’s ...

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

A South Korean research group has reported in a new paper that artificial intelligence and light-based genetic tools can work together to diagnose and stop Parkinson’s-like disease in mice. The work ...

The common myths about Parkinson’s disease and treatments - People have lots of misconceptions about Parkinson’s disease and how it develops, here are the ...

Deep brain stimulation in patients with Parkinson’s disease is linked to significant motor and daily living improvements 5 ...

Parkinson’s Disease affects around a million people in the United States. And that number is on the rise, in part because our ...

Researchers at the University of Bath, in collaboration with the Universities of Oxford and Bristol, have developed a ...

Commonly prescribed medications such as statins, non-steroidal anti-inflammatory drugs and certain blood pressure drugs may significantly delay the onset of Parkinson’s disease. The study, published ...

Parkinson’s patients taking antipsychotic medications have a significant increased risk of death, according to a new study published in JAMA Neurology and covered by News Medical. For the study, ...

When someone develops a tremor or experiences slowed movements, Parkinson’s disease often comes to mind first. However, several neurological conditions present with remarkably similar symptoms, ...